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LETTERS TO THE EDITORRegarding “A randomized double-blind trial of
upward progressive versus degressive compressive
stockings in patients with moderate to severe chronic
venous insufﬁciency”
I read with great interest the article by Couzan et al entitled
“A randomized double-blind trial of upward progressive vs degres-
sive compressive stockings in patients with moderate to severe
chronic venous insufﬁciency” and congratulate the authors on
their very interesting study.1
Their randomized double-blind trial revealed that progressive
compressive stockings are more effective than usual degressive
compressive stockings in improving pain and lower leg symptoms
in patients with chronic venous insufﬁciency.
Compressive stockings are considered an excellent adjuvant
therapy for treatment of pain and other symptoms in patients with
various leg disorders. Compression therapy is well known for
improving venous outﬂow and reducing edema by increasing the
interstitial pressure of soft tissues. Recently, we developed a novel
leg supporter with an innovative design (Fig). According to our
preliminary study with various ambulatory patients, our leg
supporter revealed a signiﬁcantly decreased degree of leg edema
and fatigue ratio and improved body stability compared with
conventional degressive compressive stockings. In terms of pressure
distribution, our leg supporter was differentiated frompreviously re-
ported graded degressive compressive stockings. Ankle pressure was
23.2 mm Hg, lower calf pressure 38.1 mm Hg, upper calf pressureFig. External appearance of the novel leg supporter.31.0 mm Hg, and knee pressure 11.8 mm Hg. As Couzan et al
implicated in their study, high ankle pressures in graded degressive
compressive stockings lead to low compliance in many elderly
patients. In addition, our leg supporter can be applied to athletes
and to standing workers. Our leg supporter has substantial versa-
tility, so it is possible to apply it to upper extremities.
Again, I thank Couzan et al for their insightful research and
hope that they will apply our novel leg supporter to their clinical
practice successfully.
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Regarding “Symptomatic venous thromboembolism
after femoral vein harvest”
We read with great interest the article by Dhanisetty et al,1
which reports a high 29% incidence of venous thromboembolism
(VTE) after femoral vein harvest (FVH), with the vast majority
of cases (16/17) being ipsilateral deep vein thrombosis distal to
the FVH site. Interestingly, in their discussion, Dhanisetty et al
suggested that therapeutic anticoagulation is not indicated imme-
diately postoperatively in patients who undergo FVH; rather, they
advocated prolonged prophylaxis with low-molecular-weight
heparin (LMWH). However, in the same article, no cases of
VTE in patients who were receiving therapeutic anticoagulation
(16%) after surgery were reported. Postoperative thrombosis was
also observed in 22% of limbs in the retained venous stump within
1 week of operation in a series reported by Wells et al,2 in which no
anticoagulants were given.
We would like to add our own experience with nine FVH
cases. All were followed up prospectively with duplex scanning,
all but one received therapeutic anticoagulation with LMWH for
10 to 30 days postoperatively, and all wore elastic stockings for
at least 3 months. We have never harvested vein length up to
the knee, always sparing the popliteal vein. Using a similar
approach, Modrall et al3 reported the absence of acute or chronic
venous morbidity if the popliteal vein was not harvested.
In most of our patients, the indication for FVHwas transposed
femoral vein arteriovenous access creation after exhaustion of access
sites in the upper limbs (Table).4 Only one popliteal stump throm-
bosis was detected in the patient who did not receive therapeutic
anticoagulation. No bleeding complications were noted.
Based on these data, we do not believe that prolonged
prophylaxis with LMWH is the best method for avoiding post-
FVH VTE as suggested by Dhanisetty et al. It remains our practice299
